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II. PARTIAL PURIFICATION OF BOVINE CARBOXYLASE
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Department of Biochemistry, Biomedical Centre, State Uniuersily Limburg, Maastricht
(The Netherlands)
(Received October l4th, 197 7 )
Summary
In this paper, we describe the isolation and partial purification of an enzyme
system that converts bovine decarboxyfactor II (PIVKA-II) into prothrombin
(factor II). It is shown that the increase in factor II activity cccurs in parallel
with 14CO2 incorporation into BaSO+ adsorbable proteins. The system is not
strictly vitamin K-dependent because it is obtained from the livers of normal
healthy cows. By preincubating the enzyme(s) with an excess of warfarin, an
absolute vitamin K1-dependence can be obtained. The reaction is inhibited by
its own product, factor IL
Introduction
The final step in the biosynthesis of prothrombin (factor II) is the modifica-
tion of 10 glutamic acid residues into 7-carboxyglutamic acid residues [1]. This
carboxylation takes place in a postribosomal enzymatic reaction, which is
vitamin K-dependent [2].Several authors have reported the development of a
rat-liver cell-free system from vitamin K-deficient rats which is able to produce
prothrombin by an O2-dependent carboxylation reaction I3-8]. In vitamin K-
deficient rats, however, the prothrombin precursors accumulate in the liver and
do not reach the blood [9]. Hence, the rat-liver cell-free system contains both
the enzyme and the substrate and this hinders further purification of the
enzyme system.
In human and cattle, the precursors of the vitamin K-dependent clotting
factors reach the blood when vitamin K antagonists are administered. We
developed a factor Il-synthesizing enzyme system by which factor II activity is
generated from separately purified prothrombin precursor (decarboxyfactor II),
obtained from coumarin-treated cows [10]. The enzyme system, which we call
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factor Il-synthetase, is obtained from normal healthy cows. In this communica-
tion we report the partial purification of the system and some of its character-
istics.
Materials and Methods
Reagents, buffers and chemicals
Buffer A: 50 mM KCl, 200 mM sucrose, 20 mM Tris ' HCl, pH 7.8. Buffer B:
50  mM KCl ,20  mM Tr is 'HCl ,  pH 7 .8 .
Vitamin K1 was obtained from Hoffmann-La Roche, Switzerland. Warfarin
(3-(c-acetonyl-benzyl)-4-hydroxycoumarin), ATP, NADH, and Triton X-100
were obtained from Sigma, U.S.A. NaH14CO3 (60 Ci/mol) and Itoc]-
formaldehyde (15 Ci/mol) were obtained from The Radiochemical Centre,
Amersham, England and Aquasol-2 from New England Nuclear, U.S.A.
All other chemicals were obtained from Merck, G.F.R.
Coagulation factors, assays and definition of units
Factor II was purified according to Owen et al. [11] and decarboxyfactor II
was described earlier [!21. Coagulation tests were performed as described by
Vermeer et al. [13]. The amount of each clotting factor present in bovine
reference plasma [13] was arbitrarily taken as 1 U/ml. In a similar way, 1 U/ml
of decarboxyfactor II was defined as the amount of precursor that gives the
same clotting time in the Echis carinofus assay [13] as the bovine reference
plasma.
Labelling of decarboxyfactor II
Decarboxyfactor II was labelled with [14C]formaldehyde [12].
Po ly acry lamide gel electrophoresis
Polyacrylamide gel electrophoresis was performed in gels containing 77o
polyacrylamide [14] in 5 mM Tris .HCl (pH 8.a)/38.4 mM glycine/1.5 mM
CaClr. This buffer was used both in the gels and in the reservoirs.
Measurement of factor II synthesis
Microsomal protein fractions (see below) were incubated in the presence of
decarboxyfactor II (0.4 U/ml), vitamin Kl (0.2 mM) and NaHCO3 (1 mM) in
buffer B. In our routine tests, reaction mixtures of 0.1 ml, containing
0.01 units of absorbance (A2ss) of microsomal proteins were incubated at 37'C
for 1.5h and subsequently diluted 4times with cold bufferB. Factorll
synthetase was defined as the activity able to decrease the one-stage clotting
time (factor II assay) of the reaction mixture during incubation due to the
production of prothrombin from decarboxyfactor II. The difference of the
clotting times before and after incubation was used to measure the amount of
factor II that had been synthesized during the reaction.
Measurement of carboxylase
The introduction of new carboxyl groups in decarboxyfactor II was
measured under similar conditions as factor II synthesis, except that unlabelled
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NaHCo3 was replaced by 20 pci NaHlacor. The reaction was stopped by
adding 1 ml ice-cold buffer containing 10 mM NaHCo3 (pH 8.0). subsequenily,
we adsorbed the reaction mixtures with 20 mg Basoa which was washed 4 times
with 10 ml NaHCo3. The BaSoa was brought into Aquasol-2 and counted as
such. Carboxylase was defined as the activity that is able to increase the
amount of BaSO+-adsorbable counts. The difference between the amounts of
adsorbed counts before and after the reaction was taken as a measure of the
activity of carboxylase in our reaction mixture.
The preparation of bouine liuer microsomes
About 100 g fresh bovine liver was taken immediately after slaughtering and
cut into 5-g pieces, rinsed with ice-cold buffer A and mixed in a waring Blendor
with 300 ml buffer A. The slurry was homogenized further in a potter
homogenizer with a tight-fitting Teflon pestle and centrifuged twice for 15 min
at t2 000 X g. The supematant was centrifuged for B0 min at 1b0 000 x g. The
pellet was washed 4 times by resuspending in 300 ml buffer B and centrifuging
for 30min at 150 000 Xg. Finally, the pellet was dissolved to 320,4266 units
and referred to as "crude microsomes".
Partial purification of factor II synthetase
crude microsomes from 30 g liver were supplemented with rriton X-100 to
a final concentration of 2vo, incubated at OoC for 30 min and centrifuged for
t h at 150 000 Xg. The supernatant was applied to a sepharose 48 column in
buffer B. The elution profile is shown in Fig. 1A. Factor II synthetase activity
was eluted at 2 positions, with different apparent molecular weights.
EFFLUENT VOLUME (mt)
Fig. 1. Fractionation of crude microsomal proteins on Sephaose 48. (A) Crude microsomes were
supplemented with Triton X-l0O to a final concentration of 2Vo (vlv). centrifuged for t h at 1bO OOO X g
and 6 ml of the supematant were appued to a Sepharose 48 column (2.5 X 1oO cm) in buffer B. (B) The
high moleculil weight activitv peak was pooled, concentrated and once more filtered through the same
column.
I
I
J t o
E
N
F
< o
u
? ' r
o
3 r o
o
t!
=
o
=
F
F
o
DILUTION FACTOR
497
Fig. 2. t 'D plots of standild reaction mixtures (see Materials and Methods) during prothrombin synthesis.
*.........".._...-*' before incubationi .--------------., aftet 45 min at 37oC; -or after 9O min at BZoC; .t-*.
factor II alone (o.4 U/ml)' The dotted l ines tepresent the values obtained. when mixtures of factor II and
decarboxyfactor II were analyzed (for details. see text).
When we rechromatographed the high molecular weight fraction on the same
column' the main part of the factor II synthetase was dissociated and eluted at
the low molecular weight position (Fig. 1B). In this wa_y, we obtained a
purification of at least 10 000 fold. The molecular weight as deterrnined on
sephadex G-100 was about 60 000. After sodium dodecyl sulphate polyacryl-
amide gel electrophoresis, the preparation, which was called "semi-purified svn-
thetase" still contained three protein bands.
Results
(A) Euidence for the generation of prothrombin
When the partially purified microsomal proteins were incubated in the
presence of decarboxyfactor II, the clotting time in the one-stage coagulation
assay decreased dramatically. This shortening of the clotting time is not caused
by a proteolytic degradation of decarboxyfactor II intt thrombin or a
thrombin-like molecule for the following reasons:
(1) When decarboxyfactor II was omitted from the reaction mixture and
replaced by factorII, no decrease of the clotting time was observed, indpendent
of the amount of factor II that was used in the experiment.
(2) rn the clotting assay no coaguration occuned in the absence of ca2*.
(3) Known thrombin inhibitors, such as diisopropylfluorophosphate,
benzamidinium chloride and hirudin did not inhibit lhe-acceleration of the
clotting time during incubation of the reaction mixture.
(4) After chromatography on sephadex G-100 columns, the newly formed
factor II activity eluted at the same position as decarboxyfactor II and factor II
and not at that of thrombin.
The shortening of the reaction mixtures clotting time was neither due to
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an increase of prothrombin precursor, which could possible be dissociated from
the microsomal proteins. This conclusion was drawn because (1) in the 2-
dimensional immunoelectrophoresis, no extra prothrombin-like material was
discovered, and (2) with the Echis carinorus assay, we did not measure more
prothrombin or prothrombin precursors after incubation of decarboxyfactor II
with microsomal proteins. So we conclude that, during this incubation, factor II
is introduced in the reaction mixture. The appearance of the newly formed
factor II, in the presence of relatively high amounts of decarboxyfactor II, can
be visualized by kinetic experiments. When the clotting time is plotted against
the dilution of factor II or decarboxyfactor II straight lines are obtained [13].
In this context, it is important to reaJize that decarboxyfactor II has some one-
stage prothrombin activity. As we pointed out earlier [72],timeldilution plots
of mixtures, containing both decarboxyfactor II and factor II, are not linear.
So a curved time/dilution plot is a strong argument for the presence of factor II
in a decarboxyfactor Il preparation. We have made a time/dilution plot of the
reaction mixture after varying incubation times (Fig.2). It is clearthatduring
incubation, the time/dilution plot flattens and becomes slightly curved. After 30
min, the line resembles the plot of a mixture containing 0.391 U/ml decarboxy-
factor II and 0.009 U/ml factor II (dotted line). After 120 min, it resembles the
plot of a mixture containing 0.378 U/ml PIVKA-II and 0.022 U/ml factor II.
The presence of factor II in the reaction mixtures after incubation can also
be deduced from experiments in which we adsorbed incubated and non-
incubated reaction mixtures to varying amounts of BaSO+ (Fig. 3). The
decarboxyfactor II in these mixtures adsorbs only to large amounts of BaSOa,
whereas the factor II in the incubated mixtures adsorbs to small amounts of
BaSO+. Therefore, the incubated mixtures show a biphasic adsorption curve.
The non-incubated mixtures on the other hand show a linear relationship
between the amount of added BaSOa and the adsorption of the "apparent"
factor II activity caused by decarboxyfactor II.
.-: i---..::3-.
__.
o  1 O O  .  2 O O
BaSOa ADDED (m9/ml )
Fig. 3. BaSO4 adsorption of factor II from standtrd reaction mixtures. o-o, before incubation;
*--*, after incubation for 1.5 h at 37oci o-o, O.03 U/ml of purif ied factor II. The mixtures
were diluted four times with buffer B and shaken for 2 min on a Vortex mixer with the indicated mount
cif BaSO4. The latter wasremoved by centrifugation and factor II was assayed in the spematmt.
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Fig.4. Polvacrvlamide gel electrophoresis of stmda.rd reaction mixtures containing 14C-labe1ed
decaboxvfactor II. .-{, before incubation; o-o, after go min at B?oc. The position of
factor II ( in a paratlel get) is marked with an anow.
(B)Eudence for the synthests of prothrombtn from ex,ternaily added
decarboxyfactor II
Now it was proven that extra factor II is introduced in the reaction mixture,
one may question whether this factor II arises either by supersession of existing
factor II by PIVKA-II from microsomal fragments, or by synthesis from a
substrate, which is already present in the microsomal fragments or by synthesis
from the decarboxyfactor II which was added to the reaction mixture. The
proof that externally-added decarboxyfactor II was converted into factor II
was given by introducing laC-labelled decarboxyfactor II into the reaction
mixtures. Before and after incubation the mixtures were submitted to poly-
acrylamide gel electrophoresis, whereafter the gels were sliced and counted. A
new peak arises after incubation at the position of factor II (Fig. 4) and the
new peak was observed only when electrophoresis was performed in the
presence of 1.5 mM CaCl2.
(C) The influence of seueral uariables on the synthesis of factor II
The synthesis of factor II by crude microsomes depends on the temperature,
the ionic conditions and-pH [10].In our more purified system, the following
opt ima were  found:  37oC,50mM KCl ,  10mM Tr is .HCl  and pH T.g-S.b .
When we investigated the dependence of the reaction on cofactors such as
vitamin K1 or HCot, it appeared necessary to work with limiting amounts of
factor II synthetase. The best results were obtained when the reaction velocity
was about 3O% of its maximal value. When high amounts of factor II synthetase
were added to the reaction mixtures, the formation of factor II was not signifi-
cantly dependent on any cofactor. Earlier experiments with crude microsomes
t10l showed that the factor Il-synthesizing system was dependent on
microsomal supernatant, ATP, Mg'*, HCOt and oxygen. When we tried to
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TABLE I
THE INFLUENCE OF SEVERAL REACTION COMPONENTS ON FACTOR I I  SYNTHETASE ACTIV-
ITY
The ATP-generating mixture contained ATP (2 mM), creatin phosphate (5 mM), and creatin phospho-
kinase (5O pg/ml). When vitmin Kl was omitted, an equal volume of the vitamin K solvent was add.ed to
the reaction mixture. DTT. dithiothreitol.
Ommission during incubation Addition during incubation Prothrombin synthesis
(U/ml)
None
Decarboxyfactor II (0.4 U/ml)
Synthetase (2 pelml)
Vitamin K1 (O.2 mM)
NaHCO3 (1  mM)
0 2 *
o.o28
o
o
o.o24
o.o27
0.028
0.o30
0.o25
o.029
microsomal spematmt
(lOVo v lv)
NADH + DDT. (0 .5  mM)
ATP generating mixture
x Th3 norr!.4I 
ltmosnhere 
was replaced by gassing the tubes for 1 min with nitrogen.
repeat those experiments with the semi-purified preparation, the results were at
variance with our earlier report (see Table I). In agreement with the observa.
t ions of Esmon and Sutt ie [15],pur i f icat ionof factor l lsynthetaseresults ina
loss of the energy dependency of the reaction. This means that ATP, qreatin
phosphate, creatin phosphokinase and Mg2* may be omitted. Neither we were
able to demonstrate any dependence of the synthesis of factor II on mibrosomal
supematant, NADH or reducing agents such as dithiothreitol. On the other
hand the reaction appea.red to be dependent on the presence of molecular
oxygen, bicarbonate and vitamin Kr. Although this cannot be concluded from
Table I, more detailed investigations lead to the conclusion that these three
cofactors are required for the conversion of decarboxyfactor II into factor II.
Prothrombin synthesis and molecular oxygen
, Wttgn we observed that the synthesis of factor II proceeded equally well in a
TABLE I I
THE INFLUENCE OF DISSOLVED O2 ON FACTOR I I -SYNTHETASE ACTIVITY
Glucose oxidase was added to a]l tubes. After adding glucose (as indicated) the tubes were gassed with
nitrogen for 1 min, closed and incubated at 37"C for 1O min. Decarboxyfactor II + vitamin Kt md factor
II syrithetaSe weie rincubated sepaately in this way. After 1O min the solution containing PIVKA-II was
added. to.ih4t coptaining factox trI-synthetase, The tubes were again gassed, either with nitrogen or oxygen
(as indicated) and incubated at 37"C. For further details see text.
Glucose oxidase
(mglml)
Glucose
(mM)
Atmosphere Prothromb'in synthesis
(U/ml)
o.5
o .5
o.5
o.5
o .5
o .5
5
5
o.5
o.5
o
o
o
o
o.oo9
o.ozL
o.026
0.o26
N2
O2
N2
O2
N2
o>
I
)
q0i
nitrogen atmosphere_ as in an oxygen atmosphere , we rearized that the oxygendissolved in our buf,fers might be iufficjent to give a normal reaction velocity.Therefore we removed the dissorved o, from"our buffers and protein solu.tions bv adding grucose (b mM) and glucose oxidasl l0.t;"gA"ii";u"H"oxygen-consuming degradation of glucose our soiutions, which were kept under
:t-1t:g:ille,came 
free from dissolved oxygen atter intunation for 10 min atd, u Irbl. when we used these solutions to compose a factorll synthesizingreaction mixture, we did not observe any synthetase activity, whereas in acontrol experiment (in which glucose was omitted) a normal synthetase activitywas found (Table II).
In the presence of an oxygen atmosphere factor II synthetase could bereactivated, so we concluded that our enzyme system is dependent on dissolvedmolecular oxygen.
Prothrombin synthesisand the carboxyration of decarboxyfactor II
{" 
,h." rat system the last step in the synthesis of frothrombin is thec.arboxvlation of ten grutamic acid residues at the N t"r;i;;i'o..rir." .idecarboxyfactor II. The source of the attached carboxyr g.o.ro is HCoj [17].Therefore we investigated whether also in the uovine"syitem prothrombin issynthesized from decarboxyfactor II and HCot. As was shown in taute r,simple omission of HCoi from the reaction -i*trrr", io", ,rot *rrri* 
".vdecrease of factor II synth.esis. However, in this case, ucot Lura be formed byth-e- solution of CO2 gas into our buffers and protein solutions. We thereforeadded to the incubation mixtures l4c-labelled NaHCo, i.rsleaa of unlabelled
NaHCo. and we measured the incorporation of label into Basoo-adsorbable
proteins (see Materials and Methods). A time-course of the reaction is given inFig. 5.
unlike the increase in factor II activity the reaction has a lag-time of about15 min. This can be explained by the presence of unrabelred co2 which is fixed
,
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120
Fig. 5. Incorporation of 14CO2 into BaSO4 adsorbable proteins during incubation of vaying reactionmixtures. 1 pmol/ml corresponds to 136 dpm/ml. r *, complete system; r r, completesystem in which vitamin K1 is replaced by warfarin (b mM)l .-., microsomal proteins alone:*-*, decrboxyfactor II alone.
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TABLE I I I
STIMULATION AND INHIBIT ION OF FACTOR I I  SYNTHETASE AND CARBOXYLASE
Reaction mixtures e'ere incubated for 1.5 h and the prothrombin synthesis was measured md expressed in
U/mi md in pmol/ml. The calculation of pmol/ml is based on the assumption that 1 l itre of nomal
bovine plasma (1 U/ml) contains 1OO mg or 1.4 pmol of factor II [2]. The 
14CO2 incorporation of
BaSOa adsorbable counts is expressed in dpm/ml md in pmol/ml. When vitamin Kl was omitted. m equal
volume of vitamin K solvents was added to the reaction mixtures.
Compound added to
reaction mixture
Prothrombin synthesized I 4CO2 incorporation
dpm/mlU/ml pmol/ml pmol/ml
None
Vitamin K1 (O.2 mM)
Warfarin (5 mM)
Macoumar (5 mM)
o .026
0 .033
o.oo3
o.oo3
46.2
4 .2
4 .2
11  900
14  600
1 200
1 600
88
107
I
t 2
already in the decarboxyfactol II converting enzyme system. Both reactions,
synthetase and carboxylase, are completely inhibited by 5 mM warfarin (see
also below).
Prothrombin synthesis and uitamin Kt
It is generally accepted that vitamin K' plays a role in the biosynthesis of
factor II. Moreover, it was shown by Shah and Suttie [17] that this vitamin is
INCUBATION TIME (min)
Fig. 6. Inhibit ion and stimulation of factor II synthetase. (A) Factor II synthesis in the presence
(r--------------r) md absence (o-) of 0.5 mM of vitamin Kl arrd in the presence of 1 mM (r=-*)'
2 mM (*_--*) and 1O mM (tr-D) of warfain, (B) Factor II synthesis in the absence of vitamin K1
(o-.-o), in the presence of 2 mM of warfain (*-*), and in the presence of 2 mM warfi l in +
o.5 mM vitamin K1 (+-x). After 4o min of incubation at 37oc the inhibited reaction mixture was
reactivated (urow) by adding eithel O.5mM of vitamin Kl (.-.) oI O.15mM of vitmin K1
(r------------.o ).
E
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required during the carboxylation of rat decarboxyprothrombin. In our system
we observed factor II synthesis in the absence of vitamin K1. As is shown in
Table III, the addition of vitamin K1 to the reaction mixture increases the
factor II synthesis only to a small extent. This is to be expected because we
used normal healthy cows for the preparation of the microsomal proteins,
so vitamin K may still be present in the enzyme system. We therefore tried to
inhibit the reaction with known vitamin K inhibitors such as warfarin and
marcoumar. In Table iII it is shown that these inhibitors are able to decrease
both, the factor II synthetase and the carboxylase activity in parallel.
A time-curve of the inhibition of factor II synthetase by warfarin is shown in
Fig. 64. Up to about 10 min tlre reaction rate is independent of the presence of
inhibitor, thereafter the reaction is strongly inhibited and after 40 min no
residual factor II synthesis occurs. After this period of time the activity of the
inhibited system can be partially restored by adding vitamin K, (Fig. 68). A
lag-time of about 10 min was observed before the reaction was started again.
(D) Feed-back inhibition of prothrombin synthesis
Looking at the time-course of factor II synthesis (Figs. 5 and 6) we see that
the increase of factor II activity gradually slows down and finally stops after
approximately 90 min. As only 5% of the added precursor is consumed at this
stage, the question arose: why does the reaction stop? The answer was found,
when we added purified factor II to the reaction mixture, prior to incubation.
The synthesis of factor II, and in parallel, the incorporation of r4co, label,
stops immediately after adding 0.02b u/ml purified factor II. when less
factor II is added, the ratio between factor II and decarboxvfactor II deter-.
mines the amount of additionally synthesized factor II.
Discussion
In our efforts to develop a bovineliver cell-free system in which prothrombin
is synthesized from its precursor we isolated a microsomal protein fraction with
the ability to decrease the clotting time of a dilution of decarboxyfactor II
from 200 to about 60 s. After we had proven that this reduction of the clotting
time was not an artifact, caused by the generation of thrombin (e.g. by a
certain proteolytic activity of the microsomal proteins) we tried to visualize the
newly formed factor II. This can be done by kinetic analysis (Fig. 2) and by
means of polyacrylamide gel electrophoresis (Fig. a). With the aid of the latter
technique we were able to show that previously labelled decarboxyfactor II
is converted into factor II, so it is clear that the externally added precusor is
used in this reaction. The enzyme(s), showing this activity we called factor II
synthetase. Bovine factor II synthetase is probably similar to the enzyme
denoted carboxylase, which is isolated from vitamin K-deficient rat livers. as
described by several authors t3-81. In the rat system the factorll synthetase
activity is related to the incorporation of 1aCO, into Basoa adsorbable proteins
(carboxylase activity). The experiments in section C show that in this respect
the bovine system is quite similar to the rat system. It should be noted that
each factor ll molecule contains 10 7-carboxyglutamic acid residues so we
expect the r4co, incorporation to be 10 times higher than the prothrombin
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synthesis (on pmol basis). The fact that we observed a t4CO, incorporation of
only 3 pmol per pmol of synthesized factor II may be due to the presence of
dissolved (unlabelled) CO2 gas in our buffers. Two observations argue in favor
of this explanation: (a) the synthesis of factor II proceeds without addition of
any NaHCO3, although NaH14CO3 is incorporated, if added, and (b) the amount
of dpm incorporated into BaSO+ adsorbable proteins varied somewhat from
one experiment to the other although the generated factor II activity was fairly
constant in all our experiments. Whether the carboxylation of decarboxy-
factor II is the only step required for its conversion into factor II remains to be
investigated. In fact, in contrast to the rat system, bovine carboxylase (factor II
synthetase) lends itself extremely well for investigations of the precise reaction
mechanism of factor II synthetase, because the enzyme and the substrate
(decarboxyfactor II) can be purified separately and analyzed before and after
reaction. The product of the reaction (factor II) can be isolated and compared
with decarboxyfactor II and normal factor II.
The main difference between this study and previous ones on rat carboxylase
lies in the fact that we purify the enzyme in a low molecular weight form from
non-deficient animals, and free from its substrate. The rat carboxylase is
obtained from vitamin K deficient rats, in which prothrombin precursors are
accumulated in the liver and in which the carboxylase activity is nihil. There-
fore rat carboxylase is highly dependent on the addition of vitamin K. On the
other hand, bovine factor II synthetase is isolated from the livers of normal
healthy cows (purification about 10 000 times). In these livers and probably
also associated with the enzyme itself, vitamin K is still present in normal
amounts. Therefore addition of the vitamin causes only a small increase in the
synthesis of factor II. Nevertheless, we conclude that factor II synthetase
requires vitamin K for its proper action, because inhibitors of vitamin K such as
warfarin were able to block the generation of factor II activity and the
incorporation of 'oCOr. In agreement with the observations of Esmon and
Suttie [15] and Helgeland [5] we found that warfarin is notagood inhibitor.
Rather large amounts (5 mM) were required to block all factor II synthesis.
This is probably due to the fact that vitamin K1 readily dissolves in non-polar
solvents and warfarin not. As vitamin K1 must be associated to carboxylase
(factor II synthetase), the binding place is probably apolar. In contrast to
vitamin K, warfarin is water-soluble, which means that it requires a polar
solvent, and will hardly bind to the vitamin K binding site in the carboxylase
enzyme system. When the appropriate amount of warfarin is added, however,
no factor II is synthesized anymore. At that moment the enzyme system
becomes highly vitamin K1 dependent, which is shown in Fig. 68.
When we try to compare our results with those obtained with the rat system,
we are hampered by the fact that the conclusions of various authors are at
variance with each other. Our result are closely similar to those obtained by
Lowenthal and Jaeger [8], which means that our system does not require ATP
[5,17],  NADH [4,51, or a reducing agent [4,5,8].  Of course i t  is possible that
several of these cofactors, like vitamin K11 or€ stil l bound to the enzyme. The
fact that limiting amounts of synthetase are required in order to measure the
dependency of the system on vitamin K and oxygen is interesting in this
respect. Only a fraction of the total enzyme population might be complexed
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with one or more cofactors (vitamin K1) or gases (cor, o2). when a limiting
amount of synthetase is incubated with an excess of decarboxyfactor II, addi-
tion of these cofactors may increase the reaction rate whereas an excess of
synthetase would be inhibited by its own product (factor II) before one of the
cofactors has run out. It is obvious that further purification of factor II
synthetase is required in order to perform more detailed studies on the mecha-
nism of the conversion of decarboxyfactor II into factor II.
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